Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $539.25M.
ENTERPRISE VALUE (EV)
$539.25M
Aclaris Therapeutics, Inc.
Market Cap
$558.65M
Enterprise Value (EV)
$539.25M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | $558.65M | $539.25M |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $556.87M | $534.71M |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $555.16M | $483.15M |
| CorMedix Inc. (CRMD)vs › | $566.03M | $454.49M |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | $555.60M |
| Delcath Systems, Inc. (DCTH)vs › | $540.95M | $495.90M |
| Aquestive Therapeutics, Inc. (AQST)vs › | $576.52M | $537.03M |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | $314.09M |
| ProKidney Corp. (PROK)vs › | $538.01M | $466.66M |
Market Cap
$558.65M
Total Debt
$551000.00
Cash
$19.96M
Enterprise Value
$539.25M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
